Crossmark

Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making

Crossref DOI link: https://doi.org/10.1186/s13048-026-02201-y

Published Online: 2026-07-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Hongfa

Jiang, Jingjing

Wang, Zhu

Wang, Wei https://orcid.org/0000-0001-7842-7301
Funding

Funding for this research was provided by:

Hebei Provincial Program for Recruiting Foreign Experts and Talent
License Information

Text and Data Mining valid from 2026-07-21

Accepted Manuscript valid from 2026-07-21
More Information

Article History

Received: 31 January 2026

Accepted: 11 July 2026

First Online: 21 July 2026

Declarations

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below